Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy
<h3>Background</h3><p dir="ltr">Progressive accumulation of α-synuclein is a key step in the pathological development of Parkinson’s disease. Impaired protein degradation and increased levels of α-synuclein may trigger a pathological aggregation <i>in vitro</i>...
Saved in:
| Main Author: | Jia-Zhen Wu (6844793) (author) |
|---|---|
| Other Authors: | Mustafa Ardah (2134240) (author), Caroline Haikal (5471201) (author), Alexander Svanbergsson (6844796) (author), Meike Diepenbroek (6844799) (author), Nishant N. Vaikath (2901785) (author), Wen Li (143214) (author), Zhan-You Wang (358606) (author), Tiago F. Outeiro (191379) (author), Omar M. El-Agnaf (3172641) (author), Jia-Yi Li (24812) (author) |
| Published: |
2019
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice
by: Mantia Karampetsou (8737815)
Published: (2017) -
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
by: Nour K. Majbour (8809316)
Published: (2016) -
A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein
by: Natalie Landeck (414147)
Published: (2016) -
Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers
by: Nishant Vaikath (3554687)
Published: (2022) -
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
by: Nour K. Majbour (8809316)
Published: (2017)